Pinealon

Pinealon is a laboratory-produced peptide composed of glutamate, aspartate, and arginine, described in the supplied guide as a bioregulator. It has been investigated for possible effects on cognition and neuronal resilience, but the supplied material does not establish clinical benefit.

The guide connects Pinealon's development to naturally occurring peptides associated with metabolic processes in the brain. It does not identify a specific precursor or provide evidence establishing that relationship. Its proposed biological relevance concerns nerve-cell function and responses to cellular stress.

The source presents modulation of neuronal activity and adaptive changes in neural connections as possible mechanisms under investigation. It also discusses potential protection against oxidative cellular injury, without specifying a molecular pathway or direct binding target. These proposals should not be interpreted as demonstrated mechanisms in humans.

1. 01

   Molecular target

2. 02

   Cellular signal

3. 03

   Biological process

LEVEL 02 · Preclinical research

Laboratory or animal research exists. Findings do not transfer reliably to people.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

The source guide portrays Pinealon as a candidate for research into cognitive performance and preservation of nerve-cell function. It also associates the compound with emotional regulation and responses to stress. The guide characterizes tolerability favorably and mentions occasional headache and transient tiredness, but supplies no supporting study details in the extracted material.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 7, Introduction to Bioregulators (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

The notes do not establish the experimental models, study quality, or extent of human investigation behind the proposed effects. Clinical relevance, reproducibility, and the claimed relationship to endogenous brain peptides remain unclear.

Safety data are limited, and the guide's favorable account is insufficient to establish a reliable adverse-effect profile. Its reports of headache and short-lived tiredness lack enough context to assess frequency or causality, while longer-term risks and interactions are not addressed. This information is not medical advice.

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 7, Introduction to Bioregulators (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

• “Pinealon peptide for cognitive enhancement”
• “Pinealon neuroprotection and brain health”
• “Pinealon for memory improvement and anti-aging”

Editorial status

source reviewed

Last updated

2026-09-14

Last reviewed

2026-09-13

Language

EN